Fatal vitamin C-associated acute renal failure

Anaesthesia and Intensive Care

Volumn 36, Issue 4, 2008, Pages 585-588

  McHugh, G J ^a,b   Graber, M L ^a,b   Freebairn, R C ^a,c  

^a PALMERSTON NORTH HOSPITAL   (New Zealand)

^b Intensive Care ^*

^c Hawke's Bay Hospital Laboratory   (United Kingdom)

Author keywords

Acute renal failure; Ascorbic acid; Autopsy; Critical care; Mental competency; Personal autonomy; Vitamin C

Indexed keywords

ASCORBIC ACID;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; CASE REPORT; CAUSE OF DEATH; DIALYSIS; ELDERLY CARE; FATALITY; HUMAN; MALE; NEPHROTOXICITY; SIDE EFFECT; TREATMENT REFUSAL;

EID: 47749133447     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0803600413     Document Type: Article

References (29)

1. Pauling L. Ascorbic acid and the common cold. Scott Med J 1973; 18:1-2.
2. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1978; 75:4538-4542.
3. Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res 1979; 39:663-681.
4. Houston DK, Johnson MA. Does vitamin C intake protect against lead toxicity? Nutr Rev 2000; 58:73-75.
5. Assouline S, Miller WH. High-dose vitamin C therapy: renewed hope or false promise? CMAJ 2006; 174:956-957.
6. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979; 301:687-690.
7. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 1985; 312:137-141.
8. Douglas RM, Hemila H, Chalker E, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2007(3):CD000980.
9. Swartz RD, Wesley JR, Somermeyer MG, Lau K. Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. Ann Intern Med 1984; 100:530-531.
10. Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA. Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 1985; 145:950-951.
11. Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J. Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 1994; 24:410-411.
12. Alkhunaizi AM, Chan L. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol 1996; 7:2320-2326.
13. Mashour S, Turner JF Jr, Merrell R. Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest 2000; 118:561-563.
14. Rathi S, Kern W, Lau K. Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report. J Med Case Reports 2007; 1:155.
15. Nankivell BJ, Murali KM. Images in clinical medicine. Renal failure from vitamin C after transplantation. N Engl J Med 2008; 358:e4.
16. Baxmann AC, De OGMC, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 2003; 63:1066-1071.
17. Gabardi S, Munz K, Ulbricht C. A review of dietary supplement-induced renal dysfunction. Clin J Am Soc Nephrol 2007; 2:757-765.
18. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003; 18:986-991.
19. Chrystal K, Allan S, Forgeson G, Isaacs R. The use of complementary/ alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 2003; 116:U296.
20. MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust 2006; 184:27-31.
21. Wilson K, Dowson C, Mangin D. Prevalence of complementary and alternative medicine use in Christchurch, New Zealand: children attending general practice versus paediatric outpatients. N Z Med J 2007; 120:U2464.
22. Albury WR, Weisz GM. The medical ethics of Erasmus and the physician-patient relationship. Med Humanit 2001; 27:35-41.
23. Paterson R. Informed consent in New Zealand: medical myths. N Z Med J 2003; 116:U628.
24. Freebairn R, Hicks P, McHugh GJ. Informed consent and the incompetent adult patient in intensive care - a New Zealand perspective. Crit Care Resusc 2002; 4:61-64.
25. The Code of Health and Disability Services Consumers' Rights. 2004. From http://www.hdc.org.nz/theact/theact-thecode Accessed March 2007.
26. Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis 1982; 2:324-336.
27. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004; 107:1-16.
28. Silfvast T, Takkunen O, Kolho E, Andersson LC, Rosenberg P. Characteristics of discrepancies between clinical and autopsy diagnoses in the intensive care unit: a 5-year review. Intensive Care Med 2003; 29:321-324.
29. Herridge MS. Autopsy in critical illness: is it obsolete? Crit Care 2003; 7:407-408.